These outcomes, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 aid the strategy of focusing on ACKR3 as a novel solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked disorders. By ticking this box https://theodorez036mkk9.ja-blog.com/profile